DAWN
NGSDay One Biopharmaceuticals Inc.
Manufacturing•Pharmaceutical Preparation Manufacturing
Watchlists:
Last updated: Friday 18th July 2025
6.50
-0.12 (-1.81%)
Prev Close:6.62
Open:6.63
Bid:6.69
Ask:6.79
52 Week Range
6.0816.76
Volume:1,346,993
Mkt Cap:666 M
40
MarketXLS Rank ®
Hold
Price Target
$7.47
+14.9%
Financial Statements
DAWN - Cash Flow (Annual)
| Dec-24 | Dec-23 | Dec-22 | Dec-21 | Invalid date | |
|---|---|---|---|---|---|
| Asset Impairment Charge | -6 M | -10 M | |||
| Capital Expenditure Reported | 19 M | 224000.0 | 26000.0 | ||
| Cash Flow From Continuing Investing Activities | -231 M | 128 M | -255 M | -8 M | |
| Change In Account Payable | 686000.0 | 2 M | -1 M | 2 M | |
| Change In Payables And Accrued Expense | 686000.0 | 2 M | -1 M | 2 M | |
| Change In Prepaid Assets | -4 M | -3 M | -846000.0 | -4 M | |
| Change In Working Capital | -15 M | -751000.0 | -2 M | -2 M | |
| Changes In Account Receivables | -14 M | ||||
| Depreciation And Amortization | 2 M | 383000.0 | 531000.0 | 199000.0 | |
| Financing Cash Flow | 203 M | 164 M | 166 M | 297 M | |
| Gain Loss On Investment Securities | -108 M | ||||
| Income Tax Paid Supplemental Data | 2 M | ||||
| Issuance Of Capital Stock | 180 M | 163 M | 162 M | 167 M | |
| Net Common Stock Issuance | 180 M | 163 M | 162 M | 167 M | |
| Net Intangibles Purchase And Sale | -17 M | ||||
| Net Investment Properties Purchase And Sale | -320 M | 129 M | -255 M | -8 M | |
| Net Investment Purchase And Sale | -320 M | 129 M | -255 M | -8 M | |
| Net PPE Purchase And Sale | 106 M | -224000.0 | -26000.0 | ||
| Net Preferred Stock Issuance | 260 M | ||||
| Other Non-cash Items | 139 M | 42 M | 36 M | 26 M | |
| Preferred Stock Issuance | 260 M | ||||
| Proceeds From Issuance Of Warrants | 21 M | ||||
| Proceeds From Stock Option Exercised | 2 M | 1 M | 4 M | ||
| Purchase Of Intangibles | -17 M | ||||
| Purchase Of Investment | -659 M | -444 M | -394 M | ||
| Purchase Of PPE | -2 M | -224000.0 | -26000.0 | ||
| Sale Of Investment | 394 M | 575 M | 139 M | ||
| Sale Of PPE | 108 M | ||||
| Stock Based Compensation | 48 M | 39 M | 27 M | 13 M | |
| Amord | 1 M | 347000.0 | 468000.0 | 179000.0 | |
| Begcash | 44 M | ||||
| Capex | 89 M | -224000.0 | -26000.0 | ||
| Cffcf | 203 M | 164 M | 166 M | 427 M | |
| Cffinv | -231 M | 128 M | -255 M | -8 M | |
| Cffoa | -78 M | -147 M | -110 M | -49 M | |
| Chgcash | -106 M | 146 M | -199 M | 241 M | |
| Chgothca | -3 M | ||||
| Chgothcl | 6 M | ||||
| Chgpay | 686000.0 | 2 M | -1 M | 2 M | |
| Chgrec | -14 M | ||||
| Comstkiss | 180 M | 163 M | 162 M | 167 M | |
| Depamor | 2 M | 36000.0 | 63000.0 | 20000.0 | |
| Endcash | -106 M | 146 M | -199 M | 284 M | |
| Fcf | -152 M | -147 M | -110 M | -49 M | |
| Netinccont | -95 M | -189 M | -142 M | -73 M | |
| Netothfin | 8 M | ||||
| Netothinv | -55 M | -3 M | -8 M | ||
| Opcf | -78 M | -147 M | -110 M | -49 M | |
| Opgainloss | -108 M | ||||
| Purchsti | -659 M | -444 M | -394 M | ||
| Salelti | 79 M | ||||
| Salesti | 314 M | 575 M | 139 M |